New insight into SDMA and cardiovascular risk in chronic kidney disease Chronic kidney disease (CKD) is a condition where the risk of heart and blood vessel problems often overshadows the dysfunction of the kidneys themselves. For years, researchers have highlighted ADMA — asymmetric dimethylarginine — as a warning sign of vascular trouble. But a recent…